Literature DB >> 19040307

Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.

Hitomi Kobayashi1, Isamu Yokoe, Masaharu Hirano, Tetsuya Nakamura, Yasuo Nakajima, Kevin R Fontaine, Jon T Giles, Yasuyuki Kobayashi.   

Abstract

OBJECTIVE: To assess cardiac involvement in asymptomatic patients with systemic sclerosis (SSc) by cardiac magnetic resonance imaging (MRI).
METHODS: Ten asymptomatic patients with SSc (all female; mean age 59.5+/-9.4 yrs) underwent contrast enhanced cardiac MRI on a 1.5 T MRI device. Adenosine triphosphate was used for stress and rest perfusion to assess perfusion defects due to microvascular impairment or ischemia, and delayed enhanced (DE) imaging was obtained for the assessment of myocardial necrosis and fibrosis. We evaluated the pathophysiological associations of stress perfusion combined with DE imaging with SSc disease severity measures.
RESULTS: Stress perfusion defects were seen in 5 out of 9 patients (56%): 4 had nonsegmental subendocardial perfusion defects and one had a segmental subendocardial perfusion defect. Three patients were found to have DE. DE was not observed in any patient without perfusion defect; and among the 5 patients with perfusion defects, 3 (60%) had DE. Two of the 3 had DE in segments not matching the region of nonsegmental perfusion defects. The remaining one had a segmental subendocardial DE matching the region of a segmental perfusion defect. Perfusion defects were seen in 75% of patients with a history of digital ulceration compared to only 20% of those without history of ulceration.
CONCLUSION: Subclinical myocardial involvement, as detected by cardiac MRI, was frequent in asymptomatic patients with SSc. Cardiac MRI may aid in understanding the pathophysiological mechanism of SSc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19040307     DOI: 10.3899/jrheum.080377

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

Review 1.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

Review 2.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

Review 3.  Points to consider when doing a trial primarily involving the heart.

Authors:  Yannick Allanore; Oliver Distler; Ulrich A Walker; Dinesh Khanna; Daniel E Furst; Christophe Meune
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 4.  Clinical Use of Cardiac Magnetic Resonance in Systemic Heart Disease.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  Eur Cardiol       Date:  2014-07

Review 5.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

6.  Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.

Authors:  Nicolò Schicchi; Gianluca Valeri; Gianluca Moroncini; Giacomo Agliata; Luca Salvolini; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2014-06-07       Impact factor: 3.469

Review 7.  The burden and measurement of cardiovascular disease in SSc.

Authors:  Mo Yin Mok; Chak Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

Review 8.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 9.  Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging.

Authors:  Giacomo De Luca; Sara Bombace; Lorenzo Monti
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-24       Impact factor: 8.667

10.  Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Maria J Overbeek; Koen T B Mouchaers; Hans M Niessen; Awal M Hadi; Koba Kupreishvili; Anco Boonstra; Alexandre E Voskuyl; Jeroen A M Belien; Egbert F Smit; Ben C Dijkmans; Anton Vonk-Noordegraaf; Katrien Grünberg
Journal:  Int J Rheumatol       Date:  2010-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.